SUBSCRIBE
SUBSCRIBE

Mergers & acquisitions

For Sale: Pfizer's $3.4 Billion Consumer Healthcare Business
Deals
Pfizer Inside Source Says Company Considering Abandoning Allergan Deal
April 5, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Companies Allergan Could Buy if Deal with Pfizer Falls Through
April 5, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
U.S. Treasury Drops Bomb on Tax Inversion Deals, Threatens Pfizer-Allergan Merger
April 5, 2016
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Why SoCal’s Acadia May Be a Perfect Takeover Target for Biogen
April 4, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Gilead Finally Makes a Buy, Snaps Up Massachusetts’ Nimbus Apollo in $1.2 Billion Deal
April 4, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Two Drugmakers Johnson & Johnson May Consider Scooping Up
April 1, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Mallinckrodt Rumored to be Eyeing Sale of Nuclear Imaging Unit, Biz Could Fetch $800 Million to $1 Billion
March 31, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
San Francisco’s Medivation Hires J.P. Morgan to Head Off Acquisition Attempts
March 31, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
For a Possible Gilead-Celgene Deal, Let Us Count the Ways
March 30, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
As Flailing Valeant Pushes Back Earnings Deadlines, Bausch & Lomb Sale Potentially on the Table
March 30, 2016
 · 
3 min read
Load More
PRESS RELEASES
Deals
Protech Adds $13 Million in Annualized Revenues With a 25% Adjusted EBITDA Margin, and Over $2.5 Million in Net Income, With the Highly Accretive Acquisition of Sleepwell, LLC
October 26, 2020
 · 
12 min read
FDA
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics’ FAAH Inhibitor Program
October 26, 2020
 · 
9 min read
Deals
Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy
October 26, 2020
 · 
7 min read
Deals
Surgalign Holdings, Inc. Announces Completion of Acquisition of Holo Surgical Inc. and its ARAI Digital Surgery Platform
October 23, 2020
 · 
6 min read
Deals
Gilead Sciences Completes Acquisition of Immunomedics, Inc.
October 23, 2020
 · 
6 min read
Deals
Retrophin Announces Agreement to Acquire Orphan Technologies
October 22, 2020
 · 
8 min read
Deals
insitro Strengthens Machine Learning-Based Drug Discovery Capabilities with Acquisition of Haystack Sciences
October 22, 2020
 · 
5 min read
Deals
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement
October 22, 2020
 · 
13 min read
Deals
Blue Sprig Pediatrics Announces Acquisition Of Momentum Autism Therapy Services
October 21, 2020
 · 
2 min read
Deals
StageBio Expands Its Global Presence With Acquisition of TPL Path Labs
October 21, 2020
 · 
4 min read
Deals
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs Merger
October 20, 2020
 · 
12 min read
Deals
Medtainer, Inc. Completes Acquisition of Advanced Container Technologies, Inc.
October 20, 2020
 · 
3 min read
Deals
Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools
October 20, 2020
 · 
2 min read
Deals
Katena Products Announces the Acquisition of Micro-Select Instruments, Inc.
October 20, 2020
 · 
2 min read
Deals
Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement
October 19, 2020
 · 
12 min read
Deals
Rafarma Closes Biocogency Merger
October 19, 2020
 · 
2 min read
Deals
Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™
October 19, 2020
 · 
8 min read
Deals
BioSpecifics to be Acquired by Endo Pharmaceuticals
October 19, 2020
 · 
8 min read
Deals
Sheridan Capital Partners-Backed Tarrytown Expocare Completes Two Acquisitions
October 19, 2020
 · 
2 min read
Deals
Lilly Announces Agreement to Acquire Disarm Therapeutics
October 15, 2020
 · 
5 min read
Load More